Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study uses pressure cuffs to treat heart failure:

This article was originally published in Clinica

Executive Summary

Vasomedical has received FDA approval to study a non-surgical treatment for congestive heart failure that involves wrapping pressurised cuffs around a patient's legs. During the procedure, known as enhanced external counterpulsation (EECP), the cuffs are inflated during diastole and deflated during systole, apparently improving the long-term blood flow to the heart during diastole. The study, which will be carried out at the Universities of Pittsburgh and California at San Francisco, is expected to be completed within 12 months.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel